User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 18:10, 15 February 2019 (diff | hist) . . (0) . . m Aspirin (→Also known as) (current)
- 13:39, 14 February 2019 (diff | hist) . . (-2) . . m Heparin-induced thrombocytopenia (HIT) (→References) (current)
- 13:39, 14 February 2019 (diff | hist) . . (-1) . . m Heparin-induced thrombocytopenia (HIT) (→References)
- 13:38, 14 February 2019 (diff | hist) . . (-1) . . m Heparin-induced thrombocytopenia (HIT) (→References)
- 08:20, 14 February 2019 (diff | hist) . . (+1) . . m Acute myeloid leukemia, FLT3-positive (→Sorafenib monotherapy {{#subobject:23822e|Regimen=1}}) (current)
- 08:20, 14 February 2019 (diff | hist) . . (-51) . . m Acute myeloid leukemia, FLT3-positive (→Maintenance after upfront therapy)
- 23:31, 13 February 2019 (diff | hist) . . (+23) . . m Small cell lung cancer (→Variant #10, 80/240 {{#subobject:7b3c2e|Variant=1}}) (current)
- 23:28, 13 February 2019 (diff | hist) . . (-8) . . m Chronic myelogenous leukemia (→Imatinib & Interferon alfa-2a {{#subobject:1ffe94|Regimen=1}}) (current)
- 23:27, 13 February 2019 (diff | hist) . . (+436) . . m Allogeneic HSCT (current)
- 23:21, 13 February 2019 (diff | hist) . . (+1) . . m Bladder cancer (→Cisplatin & Gemcitabine {{#subobject:684e48|Regimen=1}}) (current)
- 23:18, 13 February 2019 (diff | hist) . . (+126) . . m Prostate cancer (→Carboplatin & Docetaxel {{#subobject:28 |Regimen=1}}) (current)
- 23:16, 13 February 2019 (diff | hist) . . (+14) . . m Acute myeloid leukemia (→Azacitidine & Gemtuzumab ozogamicin {{#subobject:6f77be|Regimen=1}}) (current)
- 22:33, 13 February 2019 (diff | hist) . . (+26) . . m Renal cell carcinoma - historical (→Immunotherapy) (current)
- 22:32, 13 February 2019 (diff | hist) . . (+239) . . N Cyproterone acetate (Androcur) (Created page with "Antiandrogen and progestin ==Diseases for which it is used== *Prostate cancer Category:Drugs Category:Oral medications Category:Intramuscular medications C...") (current)
- 22:29, 13 February 2019 (diff | hist) . . (+143) . . N Cortisone (Created page with "Corticosteroid ==Diseases for which it was used== *Prostate cancer Category:Drugs Category:Oral medications Category:Steroids") (current)
- 22:27, 13 February 2019 (diff | hist) . . (+26) . . m Polycythemia vera (→Immunotherapy) (current)
- 22:26, 13 February 2019 (diff | hist) . . (+6) . . m Formestane (Lentaron) (current)
- 22:26, 13 February 2019 (diff | hist) . . (+159) . . N Formestane (Lentaron) (Created page with "Aromatase inhibitor ==Diseases for which it was used== *Breast cancer Category:Drugs Category:Intramuscular medications Category:Discontinued")
- 22:25, 13 February 2019 (diff | hist) . . (+132) . . N Estradiol (Created page with "Hormone replacement therapy ==Diseases for which it was used== *Breast cancer Category:Drugs Category:Oral medications") (current)
- 22:36, 12 February 2019 (diff | hist) . . (-22) . . m Acute myeloid leukemia (→Subsequent treatment)
- 22:31, 12 February 2019 (diff | hist) . . (-213) . . m Small cell lung cancer (→Teniposide monotherapy {{#subobject:60479c|Regimen=1}})
- 22:28, 12 February 2019 (diff | hist) . . (-4) . . m Prostate cancer (→Hormonotherapy)
- 22:26, 12 February 2019 (diff | hist) . . (-7) . . m Prostate cancer (→Apalutamide monotherapy {{#subobject:a70eae |Regimen=1}})
- 22:25, 12 February 2019 (diff | hist) . . (-905) . . m Pancreatic NET (→Octreotide LAR monotherapy {{#subobject:e356ea|Regimen=1}}) (current)
- 22:23, 12 February 2019 (diff | hist) . . (-35) . . m Melanoma (→Immunotherapy) (current)
- 22:22, 12 February 2019 (diff | hist) . . (-7) . . m Diffuse large B-cell lymphoma (→Axicabtagene ciloleucel monotherapy {{#subobject:78231d|Regimen=1}}) (current)
- 22:21, 12 February 2019 (diff | hist) . . (-7) . . m Primary mediastinal B-cell lymphoma (→Axicabtagene ciloleucel monotherapy {{#subobject:78231d|Regimen=1}}) (current)
- 22:21, 12 February 2019 (diff | hist) . . (-7) . . m Transformed lymphoma (→Axicabtagene ciloleucel monotherapy {{#subobject:78231d|Regimen=1}}) (current)
- 22:15, 12 February 2019 (diff | hist) . . (-7) . . m Prostate cancer (→Enzalutamide monotherapy {{#subobject:d34e0b |Regimen=1}})
- 22:12, 12 February 2019 (diff | hist) . . (+41) . . m Breast cancer, ER/PR-positive (current)
- 22:08, 12 February 2019 (diff | hist) . . (+106) . . m Acute myeloid leukemia (→Decitabine monotherapy {{#subobject:2d1dad|Regimen=1}})
- 21:59, 12 February 2019 (diff | hist) . . (-92) . . m Pancreatic cancer (→Regimen {{#subobject:57ad5f|Variant=1}}) (current)
- 11:24, 8 February 2019 (diff | hist) . . (+3) . . m Thrombotic thrombocytopenic purpura (→Caplacizumab monotherapy {{#subobject:4c678d|Regimen=1}}) (current)
- 15:44, 7 February 2019 (diff | hist) . . (+12) . . m Uveal melanoma (→TACE {{#subobject:f96a1b|Regimen=1}}) (current)
- 15:44, 7 February 2019 (diff | hist) . . (+24) . . m Hepatocellular carcinoma (current)
- 15:43, 7 February 2019 (diff | hist) . . (+40) . . m TACE (current)
- 15:41, 7 February 2019 (diff | hist) . . (+192) . . m Castleman disease (→Guidelines) (current)
- 15:40, 7 February 2019 (diff | hist) . . (-298) . . m Castleman disease (→Chemotherapy)
- 15:34, 7 February 2019 (diff | hist) . . (+6) . . m Multiple myeloma, consolidation and maintenance (→Tandem melphalan, then auto HSCT {{#subobject:dd75e9|Regimen=1}}) (current)
- 15:34, 7 February 2019 (diff | hist) . . (+4) . . m Multiple myeloma, induction (→Total Therapy {{#subobject:06fc58|Regimen=1}}) (current)
- 15:32, 7 February 2019 (diff | hist) . . (+28) . . m HLH-2004 for untreated hemophagocytic lymphohistiocytosis (HLH) (current)
- 15:31, 7 February 2019 (diff | hist) . . (+53) . . m Hemophagocytic lymphohistiocytosis (→Untreated) (current)
- 15:20, 7 February 2019 (diff | hist) . . (0) . . m Unfractionated heparin (UFH) (Jwarner moved page Heparin to Unfractionated heparin (UFH): Concept refinement) (current)
- 15:20, 7 February 2019 (diff | hist) . . (+42) . . N Heparin (Jwarner moved page Heparin to Unfractionated heparin (UFH): Concept refinement) (current)
- 14:23, 6 February 2019 (diff | hist) . . (-653) . . m Drug index (→Alphabetically)
- 14:20, 6 February 2019 (diff | hist) . . (+975) . . m Thrombotic thrombocytopenic purpura
- 14:19, 6 February 2019 (diff | hist) . . (-50) . . m Caplacizumab (Cablivi) (current)
- 14:17, 6 February 2019 (diff | hist) . . (0) . . m Caplacizumab (Cablivi) (Jwarner moved page Caplacizumab (ALX-0081) to Caplacizumab (Cablivi): FDA approval)
- 14:17, 6 February 2019 (diff | hist) . . (+36) . . N Caplacizumab (ALX-0081) (Jwarner moved page Caplacizumab (ALX-0081) to Caplacizumab (Cablivi): FDA approval) (current)
- 09:46, 6 February 2019 (diff | hist) . . (-57) . . m Venous thromboembolism (VTE) (→Heparin monotherapy {{#subobject:2a8be8|Regimen=1}})
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
